A Case of Mild Pulmonary Disease Due to Mycobacterium shimoidei with a Favorable Outcome
Author(s) -
Nadia Galizzi,
Enrico Tortoli,
Andrea Gori,
Fulvia Morini,
Giuseppe Lapadula
Publication year - 2013
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01028-13
Subject(s) - rifabutin , ethambutol , clarithromycin , mycobacterium , pulmonary disease , microbiology and biotechnology , medicine , disease , antibiotics , antimicrobial , antibacterial agent , biology , rifampicin , tuberculosis , pathology
We describe a case of mild Mycobacterium shimoidei disease with a favorable course after treatment. Characteristics of nine M. shimoidei isolates in Italy between 1989 and 2009 were also reviewed. The M. shimoidei genome was highly conserved. Based on antimicrobial susceptibility, the combination of ethambutol, clarithromycin, and rifabutin appears to be a reasonable treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom